The progression from regional hardware supplier to globally funded personalized health platform spans multiple funding stages and regulatory clearances. The trajectory shows how private equity healthcare deals converged with biotech ventures to scale operations.
| Timeframe | Entity / Venture | Capital Raised / Value | Core Milestone |
|---|---|---|---|
| Q2 2024 | ForYou Medical | Undisclosed Strategic Stake | Novo Holdings secures minority equity; supply lines expand across Nordic hospitals. |
| Q4 2024 | ForYou Care (Digital) | $2.8M Seed Round | Launches AI triage tool for ambulatory clinics; hits 45,000 active patient profiles. |
| Q2 2025 | ForYou Therapeutics | $5.4M Series Seed+ | Completes Phase I delivery trials for hydrogel-based sustained drug release. |
| Q1 2026 | ForYou Clinical OS | $8.1M Growth Equity | Integrated into 11 regional US health systems; achieves full HIPAA and SOC 2 Type II compliance. |
